Skip to main content

Table 3 Flare and irAE event management among those with a flare or irAE

From: Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy

 

n

%

Required systemic steroids

Yes

21

77.8

No

6

22.2

ICI therapy held

Yes

16

59

No

11

41

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us